Antibody neutralization of HIV-1

被引：84
|
作者：
Poignard, P [1 ]
Klasse, PJ [1 ]
Sattentau, QJ [1 ]
机构：
[1] UNIV LONDON UNIV COLL,MRC,MOLEC CELL BIOL LAB,LONDON WC1E 6BT,ENGLAND
来源：
IMMUNOLOGY TODAY | 1996年 / 17卷 / 05期
关键词：
D O I：
10.1016/0167-5699(96)10007-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Neutralizing antibodies are a major component of host defense against viruses, and appear to be particularly important in limiting the spread of cell-free virus. Results from vaccine trials in animal models suggest that these antibodies may contribute to protection against human immunodeficiency virus (HIV) infection. Here, Pascal Poignard and colleagues discuss recent developments in this area, with particular emphasis on the measurement, specificity and mechanism of the antibody response, nod ifs significance for vaccine production.
引用
收藏
页码：239 / 246
页数：8
相关论文
共 50 条
  • [1] Neutralization of HIV-1 by antibody
    Sattentau, QJ
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (04) : 540 - 545
  • [2] Antibody neutralization and escape by HIV-1
    Wei, XP
    Decker, JM
    Wang, SY
    Hui, HX
    Kappes, JC
    Wu, XY
    Salazar-Gonzalez, JF
    Salazar, MG
    Kilby, JM
    Saag, MS
    Komarova, NL
    Nowak, MA
    Hahn, BH
    Kwong, PD
    Shaw, GM
    [J]. NATURE, 2003, 422 (6929) : 307 - 312
  • [3] Antibody neutralization and escape by HIV-1
    Xiping Wei
    Julie M. Decker
    Shuyi Wang
    Huxiong Hui
    John C. Kappes
    Xiaoyun Wu
    Jesus F. Salazar-Gonzalez
    Maria G. Salazar
    J. Michael Kilby
    Michael S. Saag
    Natalia L. Komarova
    Martin A. Nowak
    Beatrice H. Hahn
    Peter D. Kwong
    George M. Shaw
    [J]. Nature, 2003, 422 : 307 - 312
  • [4] Erratum: Antibody neutralization and escape by HIV-1
    Xiping Wei
    Julie M. Decker
    Shuyi Wang
    Huxiong Hui
    John C. Kappes
    Xiaoyun Wu
    Jesus F. Salazar-Gonzalez
    Maria G. Salazar
    J. Michael Kilby
    Michael S. Saag
    Natalia L. Komarova
    Martin A. Nowak
    Beatrice H. Hahn
    Peter D. Kwong
    George M. Shaw
    [J]. Nature, 2003, 423 : 197 - 197
  • [5] Antibody Epitope Exposure and Neutralization of HIV-1
    Pantophlet, Ralph A.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (33) : 3729 - 3743
  • [6] Enhanced HIV-1 neutralization by antibody heteroligation
    Mouquet, Hugo
    Warncke, Malte
    Scheid, Johannes F.
    Seaman, Michael S.
    Nussenzweig, Michel C.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (03) : 875 - 880
  • [7] Antibody neutralization of HIV-1 and the potential for vaccine design
    Sattentau, QJ
    Moulard, M
    Brivet, B
    Botto, F
    Guillemot, JC
    Mondor, I
    Poignard, P
    Ugolini, S
    [J]. IMMUNOLOGY LETTERS, 1999, 66 (1-3) : 143 - 149
  • [8] Correlations Between HIV-1 Clades and HIV-1 Antibody Neutralization Sensitivity: Significant for Vaccine Development?
    van Gils, Marit J.
    Schuitemaker, Hanneke
    [J]. CURRENT HIV RESEARCH, 2010, 8 (08) : 579 - 586
  • [9] NEUTRALIZATION OF INVIVO HIV-1 INFECTIVITY MEDIATED BY INVITRO NEUTRALIZING ANTIBODY
    EMINI, EA
    NARA, PL
    EICHBERG, J
    LEWIS, JA
    MATSUSHITA, S
    PUTNEY, SD
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (01) : 37 - 38
  • [10] Mechanism of HIV-1 Neutralization by an Antibody: Reversible Binding Stalls Entry
    Kabat, David
    Platt, Emily
    [J]. ANTIVIRAL RESEARCH, 2011, 90 (02) : A23 - A23
12345